Not applicableStudy completedNCT01057199What this trial is testingStudying Biomarkers in Cell Samples From Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 6
Not applicableStudy completedNCT01138332What this trial is testingBiomarkers in Young Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 20
Early research (Phase 1)Ended earlyNCT06965881What this trial is testingStudy to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy AdultsWho this might be right forTuberous Sclerosis Complex (TSC)Focal Cortical DysplasiaOther Neurological Disorders GRIN Therapeutics, Inc. 30
Early research (Phase 1)Active Not RecruitingNCT05385692What this trial is testingBL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid TumorsWho this might be right forLocally Advanced or Metastatic Digestive Tract TumorsSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 22
Testing effectiveness (Phase 2)Ended earlyNCT03860207What this trial is testingStudy of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor CancersWho this might be right forNeuroblastomaOsteosarcomaOther Solid Tumor Cancers Y-mAbs Therapeutics 12
Early research (Phase 1)Study completedNCT01877811What this trial is testingStudy of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid TumorsWho this might be right forSolid Tumors Hoffmann-La Roche 143
Not applicableLooking for participantsNCT03300830What this trial is testingMolecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman DiseaseWho this might be right forHuman Immunodeficiency VirusCastleman's DiseaseKaposi's Sarcoma+1 more National Cancer Institute (NCI) 280
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07340619What this trial is testingClinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.Who this might be right forMetastatic (Stage IV) Melanoma UNICANCER 51
Testing effectiveness (Phase 2)Looking for participantsNCT06891157What this trial is testingChidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular SubtypesWho this might be right forChidamideR-CHOP ChemotherapyDLBCL - Diffuse Large B Cell Lymphoma+1 more The First Affiliated Hospital with Nanjing Medical University 148
Testing effectiveness (Phase 2)Looking for participantsNCT06008054What this trial is testingSI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal TumorsWho this might be right forEsophageal CancerGastric CancerColorectal Cancer Sichuan Baili Pharmaceutical Co., Ltd. 376
Early research (Phase 1)Study completedNCT02952729What this trial is testingStudy of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2Who this might be right forAdvanced Breast CancerAdvanced Nonsmall Cell Lung CancerAdvanced Gastric Cancer Mersana Therapeutics 120
Testing effectiveness (Phase 2)Study completedNCT03273712What this trial is testingDosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)Who this might be right forNeuroendocrine TumorsMeningiomaNeuroblastoma+1 more University of Iowa 39
Testing effectiveness (Phase 2)Study completedNCT02474186What this trial is testingPhase II Study for Solid Metastatic TumorsWho this might be right forBreast CancerMetastatic Breast CancerSolid Tumor NYU Langone Health 41
Testing effectiveness (Phase 2)Study completedNCT04993677What this trial is testingSEA-CD40 Given With Other Drugs in CancersWho this might be right forMelanomaCarcinoma, Non-Small- Cell Lung Seagen Inc. 77
Testing effectiveness (Phase 2)Study completedNCT01484873What this trial is testingWeight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain TumorWho this might be right forObesityOverweightCraniopharyngioma Vanderbilt University Medical Center 10
Early research (Phase 1)Ended earlyNCT06008483What this trial is testingA Dose Finding Study to Treat Bone Tumor(s)Who this might be right forBone CancerBone TumorSolid Tumor+2 more QSAM Therapeutics, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT00025441What this trial is testingCombination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsWho this might be right forOvarian CancerSarcomaSmall Intestine Cancer Societe Internationale d'Oncologie Pediatrique
Testing effectiveness (Phase 2)Ended earlyNCT04066894What this trial is testingSacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE StudyWho this might be right forLow Anterior Resection SyndromeMalignant Anal NeoplasmMalignant Bladder Neoplasm+8 more M.D. Anderson Cancer Center 3
Early research (Phase 1)Not Yet RecruitingNCT06358053What this trial is testingCRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced CancersWho this might be right forCervical CancerAnal CancerHead and Neck Cancers+1 more Corregene Biotechnology Co., Ltd 24
Testing effectiveness (Phase 2)Ended earlyNCT00095862What this trial is testingVaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive CancersWho this might be right forBreast CancerUnspecified Adult Solid Tumor, Protocol Specific Wiseman Research Initiatives LLC 24